'For the quarter ending June 2024, consolidated Net sales (including other operating income) of Torrent Pharmaceuticals has increased 10.34% to Rs 2859 crore compared to quarter ended June 2023.Operating profit margin has jumped from 30.53% to 31.62%, leading to 14.29% rise in operating profit to Rs 904.00 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 16.57% to 14.23%.   Purchase of finished goods cost rose from 9.52% to 10.83%.   Employee cost increased from 19.00% to 19.04%.   Other expenses fell from 24.79% to 24.61%.   

Other income fell 29.41% to Rs 24 crore.  PBIDT rose 12.48% to Rs 928 crore.  Provision for interest fell 27.18% to Rs 75 crore.  

PBDT rose 18.14% to Rs 853 crore.  Provision for depreciation rose 3.14% to Rs 197 crore.  

Profit before tax grew 23.54% to Rs 656.00 crore.  Share of pr...

• 

  (13-Jan-2025)

  Avenue Supermarts

  Revenue up 17.7% YoY, Net profit up 4.8% YoY in Q3FY2025

• 

  (12-Jan-2025)

  Just Dial

  Sales up 8%, net up 43%

• 

  (10-Jan-2025)

  PCBL

  Lower profits

• 

  (10-Jan-2025)

  Tata Consultancy Services

  Revenue up 5.6% YoY to Rs 63973 crore in Q3FY2025